Clinical Trials
We conduct trials to test promising treatments.
Showing 10 of 36 Clinical Trials
-
CCTG MA.39
CCTG MA.39: Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Breast Cancer.
-
CHAMPION-AF
WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation
-
COMET AFT-25
Comparing an Operative to Monitoring and Endocrine Therapy (COMET)Trial for low risk DCIS: A Phase III Prospective Randomized Trial.
-
CYSVIEW
Blue Light Cystoscopy with Cysview (BLC with Cysview)Registry
-
EA1131
EA1131: A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Breast Cancer following Neoadjuvant Chemotherapy.
-
EA1242 RxFINE-Low
EA1242: A Phase III Trial of Rx Therapy Guided by Genomic Risk
-
EA8143
A Phase 3 Randomized Study Comparing Perioperative Nivolumab vs. Observation in Patients with Renal Cell Carcinoma Undergoing Nephrectomy
-
EA8184
EA8184: A Phase II Randomized Double Blinded Study of Green Tea Catechins (GTC) vs. Placebo in Men on Active Surveillance for Prostate Cancer: Modulation of Biological and Clinical Intermediate Biomarkers.
-
GERD Research Project
The effect of Transoral Incisionless Fundoplication procedure prior to Sleeve Gastrectomy versus Gastric Bypass on reflux symptoms in bariatric patients with Gastroesophageal Reflux Disease
-
NRG-CC011
Cognitive Training for cancer related cognitive impairment in breast cancer survivors: a multi-center randomized double-blinded controlled trial.





